|
||||||
Executive Summary Pernix Therapeutics Holdings Inc (PTX)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better. The profile contains critical company information including: - Business description-A detailed description of the company's operations and business divisions. - Corporate strategy-Analyst's summarization of the company's business strategy. - SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats. - Company history-Progression of key events associated with the company. - Major products and services-A list of major products, services and brands of the company. - Key competitors-A list of key competitors to the company. - Key employees-A list of the key executives of the company. - Executive biographies-A brief summary of the executives' employment history. - Key operational heads-A list of personnel heading key departments/functions. - Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company. - Key manufacturing facilities-A list of key manufacturing facilities of the company. - Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history. - Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history. Highlights Pernix Therapeutics Holdings Inc (Pernix Therapeutics) is a specialty pharmaceutical company that discovers, develops, and markets generic pharmaceutical products. The company's portfolio encompasses a fixed dose combination product prescribed to treat acute migraine; an extended-release (XR) opioid agonist that is indicated for pain severe management, and long-term opioid treatment; a non-narcotic, non-addictive, and non-scheduled prescription sleep aid to treat insomnia; an antibiotic for infections of middle ear; and indications for depressive disorder in adults. Its branded and generic pharmaceuticals products span the therapeutic areas of neurology, psychiatry, and pain management. The company serves drug wholesalers, retail drug stores, and mass merchandisers. It has subsidiaries in the US and Ireland. Pernix Therapeutics is headquartered in Morristown, New Jersey, the US. Pernix Therapeutics Holdings Inc Key Recent Developments May 10,2018: Pernix Therapeutics Reports First Quarter 2018 Financial Results Apr 23,2018: Pernix Therapeutics Announces Participation in Lead Bid for Acquisition of Worldwide Rights to Contrave for Weight Loss Mar 08,2018: Pernix Therapeutics Reports Fourth Quarter and Full Year 2017 Financial Results Feb 06,2018: Pernix Announces Appointment of Lead Independent Director and Key Management Team Promotion Nov 16,2017: Pernix Therapeutics Announces Election of Two Healthcare Industry Veterans to Board of Directors Key benefits of buying this profile include: You get detailed information about the company and its operations to identify potential customers and suppliers. - The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors. Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company. - The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events. Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably. - Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted. Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance. - Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios. Gain key insights into the company for academic or business research. - Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs. Note: Some sections may be missing if data is unavailable for the company Read More Contact Us:
Table of Contents Table of Contents 3 List of Tables 5 List of Figures 5 Section 1-About the Company 6 Pernix Therapeutics Holdings Inc-Key Facts 6 Pernix Therapeutics Holdings Inc-Key Employees 7 Pernix Therapeutics Holdings Inc-Key Employee Biographies 8 Pernix Therapeutics Holdings Inc-Major Products and Services 9 Pernix Therapeutics Holdings Inc-History 10 Pernix Therapeutics Holdings Inc-Company Statement 11 Pernix Therapeutics Holdings Inc-Locations And Subsidiaries 14 Head Office 14 Other Locations & Subsidiaries 14 Section 2-Company Analysis 15 Company Overview 15 Pernix Therapeutics Holdings Inc-Business Description 16 R&D Overview 16 Pernix Therapeutics Holdings Inc-SWOT Analysis 17 SWOT Analysis-Overview 17 Pernix Therapeutics Holdings Inc-Strengths 17 Pernix Therapeutics Holdings Inc-Weaknesses 18 Pernix Therapeutics Holdings Inc-Opportunities 19 Pernix Therapeutics Holdings Inc-Threats 20 Pernix Therapeutics Holdings Inc-Key Competitors 21 Section 3-Company Financial Ratios 22 Financial Ratios-Capital Market Ratios 22 Financial Ratios-Annual Ratios 23 Performance Chart 26 Financial Performance 26 Financial Ratios-Interim Ratios 27 Financial Ratios-Ratio Charts 28 Section 4-Company's Lifesciences Financial Deals and Alliances 29 Pernix Therapeutics Holdings Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 29 Pernix Therapeutics Holdings Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 30 Pernix Therapeutics Holdings Inc, Recent Deals Summary 31 Section 5-Company's Recent Developments 32 May 10, 2018: Pernix Therapeutics Reports First Quarter 2018 Financial Results 32 Mar 08, 2018: Pernix Therapeutics Reports Fourth Quarter and Full Year 2017 Financial Results 33 Feb 06, 2018: Pernix Announces Appointment of Lead Independent Director and Key Management Team Promotion 36 Nov 16, 2017: Pernix Therapeutics Announces Election of Two Healthcare Industry Veterans to Board of Directors 37 Nov 07, 2017: Pernix Therapeutics Reports Third Quarter 2017 Financial Results 38 Oct 17, 2017: Pernix Therapeutics Announces Planned Departure of Chief Financial Officer 41 Jul 27, 2017: Pernix Therapeutics Reports Second Quarter 2017 Financial Results and Provides Business Update 42 Jul 20, 2017: Pernix Therapeutics Pre-Announces Certain Preliminary Second Quarter 2017 Financial Results 45 May 15, 2017: Pernix Therapeutics Reports First Quarter 2017 Financial Results and Provides Business Update 47 Mar 28, 2017: Pernix Therapeutics Announces Fourth Quarter And Full Year 2016 Financial Results 49 Section 6-Appendix 53 Methodology 53 Ratio Definitions 53 About GlobalData 57 Contact Us 57 Disclaimer 57 List of Figures Pernix Therapeutics Holdings Inc, Performance Chart (2013-2017) 26 Pernix Therapeutics Holdings Inc, Ratio Charts 28 Pernix Therapeutics Holdings Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 29 Pernix Therapeutics Holdings Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 30 List of Tables Pernix Therapeutics Holdings Inc, Key Facts 6 Pernix Therapeutics Holdings Inc, Key Employees 7 Pernix Therapeutics Holdings Inc, Key Employee Biographies 8 Pernix Therapeutics Holdings Inc, Major Products and Services 9 Pernix Therapeutics Holdings Inc, History 10 Pernix Therapeutics Holdings Inc, Subsidiaries 14 Pernix Therapeutics Holdings Inc, Key Competitors 21 Pernix Therapeutics Holdings Inc, Ratios based on current share price 22 Pernix Therapeutics Holdings Inc, Annual Ratios 23 Pernix Therapeutics Holdings Inc, Annual Ratios (Cont...1) 24 Pernix Therapeutics Holdings Inc, Annual Ratios (Cont...2) 25 Pernix Therapeutics Holdings Inc, Interim Ratios 27 Pernix Therapeutics Holdings Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 29 Pernix Therapeutics Holdings Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 30 Pernix Therapeutics Holdings Inc, Recent Deals Summary 31 Currency Codes 53 Capital Market Ratios 53 Equity Ratios 54 Profitability Ratios 54 Cost Ratios 55 Liquidity Ratios 55 Leverage Ratios 56 Efficiency Ratios 56 Single User License: Site License: Corporate User License: Vanda Pharmaceuticals Inc Pfizer Inc Adamis Pharmaceuticals Corp Pernix Therapeutics Holdings Inc, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts |
select a license |
||
NEWSLETTER BY CATEGORY
|
||
Testimonials
|
||
The report was very informative and gives me an interesting view on the Indian market.... "Area Sales Manager, Muhlen Sohn GmbH & Co. KG"We would like to thank the entire team of Ken Research in showcasing professionalism in research and quick turnaround time. We have had multiple research reports from Ken Research. The deadline communicated for research was duly met. The research reports were covering many aspects in detail. This showcases their endeavor and care for client satisfaction and a strong understanding of the clients’ requirements. Thank you again for your help... "Group Vice President Strategy, Aliaxis"I appreciate their diligence and determination in customizing the research project. The data proves to be valuable and accurate. I would, in future, definitely use their services again... "Technical Marketing Manager, Ascendis Health Limited"I would like to thank Ken research team for meeting our report deliverables. The report is very good and we appreciate your well cooperation. ... "., Coldwell Banker - Riyadh "The research you conducted was very helpful for us and the integrity of your research approach gave us great confidence in the data. Look forward to collaborating again in future... "International and Business Dev. Director, Duta Abadi Primantara" |